Valeant continues to enhance its skin care offerings through PreCision Dermatology purchase
Valeant Pharmaceuticals International Inc. is acquiring private skin care firm PreCision Dermatology Inc. for $475mm in cash, plus $25mm in sales-based earn-outs.
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com